Ask Warren

CKD Bio

063160 · KOSPI · ₩063160 · 종근당바이오

₩12,350▼ ₩30 (0.24%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩41B₩41B₩42B₩34B₩41B₩43B₩31B₩44B
Cost of sales₩40B₩36B₩37B₩28B₩32B₩34B₩25B₩35B
Gross profit₩1.3B₩5B₩5B₩5.9B₩9.2B₩8.7B₩6.2B₩9B
Operating income−₩5B−₩1.7B₩109M−₩1.5B₩2.9B₩2.1B₩209M₩2.6B
Net income−₩3.4B−₩2B−₩709M−₩1.7B−₩1.4B₩900M₩8.4B−₩4.1B
Net income to shareholders−₩3.4B−₩2B−₩709M−₩1.7B−₩1.4B₩900M₩8.4B−₩4.1B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩293B₩298B₩300B₩295B₩292B₩294B₩284B₩291B
Current assets₩132B₩136B₩136B₩133B₩128B₩127B₩115B₩119B
Cash and equivalents₩517M₩956M₩1.4B₩971M₩1.4B₩540M₩1.1B₩4.8B
Total liabilities₩173B₩173B₩173B₩167B₩162B₩163B₩153B₩161B
Current liabilities₩125B₩124B₩152B₩144B₩102B₩101B₩91B₩96B
Borrowings₩146B₩146B₩143B₩138B₩136B₩136B₩130B₩138B
Total equity₩120B₩125B₩127B₩129B₩131B₩131B₩131B₩130B
Shareholders' equity₩120B₩125B₩127B₩129B₩131B₩131B₩131B₩130B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩2.6B₩772M−₩908M−₩1.5B₩3.2B−₩5B₩222M₩4.2B
Capital spending₩3.4B₩3.6B₩2.8B₩973M₩1.8B₩1.2B₩826M₩781M
Free cash flow−₩749M−₩2.8B−₩3.8B−₩2.4B₩1.4B−₩6.1B−₩604M₩3.4B
Dividends paid₩0₩0₩0₩0₩0₩549M₩0₩0

Consolidated where available. Amounts in won.

Also known as: CKD Bio / 종근당바이오 / 063160 / KRX:063160

Source: KRX statistical information